End-of-day quote
Korea S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
142,500
KRW
|
+0.42%
|
|
+2.89%
|
+3.71%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
337,294
|
380,342
|
532,950
|
1,094,685
|
770,770
|
678,566
|
Enterprise Value (EV)
1 |
332,261
|
339,496
|
466,197
|
1,060,813
|
766,512
|
612,002
|
P/E ratio
|
9.32
x
|
9.55
x
|
15.4
x
|
13.7
x
|
11.9
x
|
36.6
x
|
Yield
|
-
|
2.35%
|
1.63%
|
0.96%
|
1.49%
|
1.53%
|
Capitalization / Revenue
|
0.94
x
|
1.01
x
|
1.43
x
|
2.06
x
|
1.26
x
|
1.55
x
|
EV / Revenue
|
0.92
x
|
0.9
x
|
1.25
x
|
2
x
|
1.25
x
|
1.4
x
|
EV / EBITDA
|
6.12
x
|
5.44
x
|
7.09
x
|
9.49
x
|
7.58
x
|
12.1
x
|
EV / FCF
|
-
|
9,959,597
x
|
11,422,103
x
|
-32,383,589
x
|
-26,570,757
x
|
7,845,061
x
|
FCF Yield
|
-
|
0%
|
0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
1.53
x
|
1.51
x
|
2.04
x
|
3.36
x
|
2.03
x
|
1.79
x
|
Nbr of stocks (in thousands)
|
5,221
|
5,268
|
5,100
|
5,010
|
5,005
|
4,939
|
Reference price
2 |
64,600
|
72,200
|
104,500
|
218,500
|
154,000
|
137,400
|
Announcement Date
|
3/11/20
|
3/11/20
|
3/10/21
|
3/17/22
|
3/15/23
|
3/13/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
360,435
|
377,851
|
371,990
|
531,343
|
611,650
|
437,673
|
EBITDA
1 |
54,282
|
62,441
|
65,716
|
111,784
|
101,140
|
50,742
|
EBIT
1 |
40,031
|
46,588
|
49,208
|
95,032
|
80,853
|
22,527
|
Operating Margin
|
11.11%
|
12.33%
|
13.23%
|
17.89%
|
13.22%
|
5.15%
|
Earnings before Tax (EBT)
1 |
44,676
|
49,229
|
45,795
|
105,499
|
84,896
|
27,013
|
Net income
1 |
35,974
|
39,565
|
34,666
|
79,903
|
64,824
|
18,605
|
Net margin
|
9.98%
|
10.47%
|
9.32%
|
15.04%
|
10.6%
|
4.25%
|
EPS
2 |
6,932
|
7,559
|
6,769
|
15,897
|
12,932
|
3,758
|
Free Cash Flow
|
-
|
34,087
|
40,815
|
-32,758
|
-28,848
|
78,011
|
FCF margin
|
-
|
9.02%
|
10.97%
|
-6.17%
|
-4.72%
|
17.82%
|
FCF Conversion (EBITDA)
|
-
|
54.59%
|
62.11%
|
-
|
-
|
153.74%
|
FCF Conversion (Net income)
|
-
|
86.15%
|
117.74%
|
-
|
-
|
419.31%
|
Dividend per Share
|
-
|
1,700
|
1,700
|
2,100
|
2,300
|
2,100
|
Announcement Date
|
3/11/20
|
3/11/20
|
3/10/21
|
3/17/22
|
3/15/23
|
3/13/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
5,033
|
40,846
|
66,753
|
33,872
|
4,258
|
66,564
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
34,087
|
40,815
|
-32,758
|
-28,848
|
78,011
|
ROE (net income / shareholders' equity)
|
-
|
16.8%
|
13.6%
|
27.2%
|
18.4%
|
4.95%
|
ROA (Net income/ Total Assets)
|
-
|
9.9%
|
9.63%
|
15.5%
|
11.1%
|
3.01%
|
Assets
1 |
-
|
399,851
|
360,103
|
514,728
|
586,151
|
619,040
|
Book Value Per Share
2 |
42,201
|
47,872
|
51,194
|
65,109
|
75,680
|
76,567
|
Cash Flow per Share
2 |
1,640
|
10,159
|
15,671
|
12,071
|
8,400
|
20,388
|
Capex
1 |
26,649
|
19,428
|
20,554
|
45,605
|
50,585
|
25,347
|
Capex / Sales
|
7.39%
|
5.14%
|
5.53%
|
8.58%
|
8.27%
|
5.79%
|
Announcement Date
|
3/11/20
|
3/11/20
|
3/10/21
|
3/17/22
|
3/15/23
|
3/13/24
|
|
1st Jan change
|
Capi.
|
---|
| +3.71% | 508M | | +17.73% | 66.69B | | +1.61% | 49.2B | | +16.33% | 41.24B | | +18.68% | 25.89B | | +12.78% | 19.81B | | -21.87% | 15.86B | | -10.29% | 15.23B | | +2.32% | 15.35B | | -22.30% | 13.36B |
Other Specialty Chemicals
|